Kestra Likely To Report Q1 Loss; These Most Accurate Analysts Revise Forecasts Ahead Of Earnings Call

Kestra Medical Technologies, Ltd. (NASDAQ: KMTS) will release its first earnings report after the closing bell on Monday, Sept. 14. Analysts expect the Kirkland, Washington-based company to report quarterly loss of 62 cents per share, versus a loss of 36 cents per share in the year-ago period. The consensus estimate for Kestra Medical Technologies’ quarterly revenue is $29.01 million. It reported $19.37 million last year, according to Benzinga Pro. On Sept. 10, Kestra named Daniel Finney as Vice President of Research & Development. Kestra Medical Technologies shares declined 2.1% to close at $23.57 on Thursday.